22.05.2024 - Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that three submitted .
More than 100 people gathered in front of UM’s Main Hall at noon Friday to call for the resignation or firing of Rob Smith, whose blog filled with misogynistic writings